|
|
 |
|
Viewing report
|
|
|
|
Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market
GBI Research, March 2011, Pages: 109
Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market
Summary
GBI Research's report, “Upstream Processing in Biopharmaceuticals - Increasing Use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market”, provides the key to market data on overall upstream process, Contract Manufacturing Organization (CMO) market for upstream processing, and the cell culture and reagent market. Market. The report also analyzes the strengths, weaknesses, opportunities, and threats for the key players in the CMO and cell culture and regent market. The report also discusses the key market drivers and restraints for the upstream processing, outsourcing to CMO and cell culture and reagent market. The report is based on proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts to provide a comprehensive view of the upstream processing in biopharmaceuticals.
Scope
The scope of this report includes -
- Key emerging technologies in upstream processing for the manufacturers of Biopharmaceuticals in the pharmaceuticals industry
- Market revenues and forecasts for upstream Processing of Biopharmaceuticals in the CMO market from 2009 to 2016.
- Key drivers, restraints challenges and trends in upstream processing.
- Technology landscape along with their application in upstream bioprocess that shape the bio manufacturing industry
- Analysis of competitive assessment of key CMO and cell culture and reagent players.
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Formulate strategies to increase your company’s growth by understanding the new growth opportunities, market size and growth prospectus in the upstream market.
- Work around the technology hurdles by identifying the key trends shaping and driving the market for upstream process.
- Differentiate yourself from competitors and develop new solutions for the bio pharmaceutical manufacturing industry by understanding the existing competitive landscape and how it is evolving to meet the increasing demands.
- Draft efficient strategies by understanding best practices, identifying key players in the CMO market and cell culture and regent market.
|
|
|
|
